Penumbra, Inc. Reports First Quarter 2026 Financial Results
Go back to Penumbra, Inc. Reports First Quarter 2026 Financial Results| Boston Scientific (NYSE: BSX) | Delayed: 46.91 -0.26 (0.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.17 | 52 Week High | $24.79 | |||
| Open | $47.60 | 52 Week Low | $15.67 | |||
| Day High | $47.80 | P/E | N/A | |||
| Day Low | $45.99 | EPS | $-0.09 | |||
| Volume | 16,762,001 | |||||
| (NYSE: PEN) | Delayed: 318.71 +0.39 (0.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $318.32 | 52 Week High | $79.49 | |||
| Open | $320.26 | 52 Week Low | $40.23 | |||
| Day High | $321.80 | P/E | N/A | |||
| Day Low | $317.53 | EPS | $0.00 | |||
| Volume | 514,479 | |||||
